Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARA 290 for Complex Regional Pain Syndrome type 1 (CRPS I)
2012-003688-24Phase 2Active
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2012
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Complex Regional Pain Syndrome Type 1 (CRPS-1) comparing ARA 290 with Placebo (2 arms). Primary endpoints: Pain now numerical rating score during 4 weeks of treatment, Global health self-assessment during 4 weeks of treatment and 1 more. Started Sep 2012; status: active.
02
Drugs
cibinetide
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)
Beyond the preview
Go deeper on 2012-003688-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003688-24.